The Bipartisan Heroin Task Force, led by Representatives Annie Kuster (D-NH), Tom MacArthur (R-NJ), Brian Fitzpatrick (R-PA), and Donald Norcross (D-NJ), is urging President Trump to renew the public health emergency declaration of the opioid epidemic and provide the necessary funding to support it. The public health emergency declaration will expire on January 22, 2018. Forty-six additional membe... Read more »

Today, Congresswoman Annie Kuster (NH-02), the founder and co-chair of the Bipartisan Heroin Task Force, released the following statement on reports that the Trump Administration intends to cut funding for the Office of National Drug Control Policy (ONDCP) by 95 percent. The ONDCP is critical to coordinating the federal response to the opioid epidemic that is negatively impacting communities throu... Read more »

Introducing the Bipartisan Heroin Task Force's legislative agenda for 2018 You can watch the press conference HERE. Hello Friend, Last week, I joined with members of the Bipartisan Heroin Task Force to release our legislative agenda for 2018. In the years since I formed the Task Force, it has grown in size to 100 Members of Congress, both Republicans and Democrats, underscoring the widespread imp... Read more »

(Concord, NH) – Today Congresswoman Annie Kuster (NH-02), the founder and co-chair of the Bipartisan Heroin Task Force, blasted the decision by President Trump to suspend the National Registry of Evidence-based Programs and Practices (NREPP), which promotes scientifically supported practices and programs to treat substance-use disorders and mental disorders. NREPP is run by the Substance Abuse and... Read more »

Congresswoman Annie Kuster (NH-02), the founder and co-chair of the Bipartisan Heroin Task Force, released the following statement on President Trump signing the INTERDICT Act into law. The bill ensures that Customs and Border Protection (CBP) has the new screening devices, laboratory equipment, facilities, and personnel they need to detect and intercept fentanyl and other synthetic opioids. The I... Read more »

**Kuster legislative agenda item signed into law in November** **The press conference can be watched HERE** **The press conference can be watched HERE** [January 10, 2018 – Washington, DC – Congresswoman Annie Kuster (NH-02) stands with members of the Bipartisan Heroin Task Force to announce the 2018 legislative agenda] A high-definition version of the photo is available HERE. Today, the Bipartisa... Read more »

(Concord, NH) - Congresswoman Annie Kuster (NH-02), the founder and co-chair of the Bipartisan Heroin Task Force, applauded passage of the INTERDICT Act in the Senate. The legislation will now head to the President's desk for his signature. The bill ensures that Customs and Border Protection (CBP) has the new screening devices, laboratory equipment, facilities, and personnel they need to detect an... Read more »

Congresswoman Annie Kuster (NH-02), the founder and co-chair of the Bipartisan Heroin Task Force, released the following statement on the Centers for Disease Control and Prevention (CDC) report showing that New Hampshire has the third highest overdose death rate in the country. “This report is deeply troubling and underscores the need for additional action and resources to take on the opioid epide... Read more »

Dear Friend, Last week, I was excited to visit Valley Regional Hospital in Claremont and join with hospital officials to announce that the U.S. Department of Agriculture (USDA) Rural Development has approved a $19.5 million Community Facilities Loan to Valley Regional. This loan will provide significant savings that the hospital will use to develop residential intensive treatment programs for peop... Read more »

Congresswoman Annie Kuster (NH-02) and Carol Shea-Porter (NH-01) joined Representatives Dave Loebsack (IA-02) and Grace Napolitano (CA-32) today to introduce legislation to secure resources to directly combat the devastating opioid epidemic that has swept the nation. The Combating the Opioid Epidemic Act invests $45 billion into the prevention, detection, surveillance and treatment of opioid abuse... Read more »